Optimized serum stability and specificity of an αvβ6 integrin-binding peptide for tumor targeting
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 296, 100657
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation
- National Institutes of Health (R01AG063845, R01CA177272, R21NS099654)
- National Science Foundation LFO (DGE-1762114)
- National Institute of Health
This publication has 67 references indexed in Scilit:
- Clinical significance of integrin αvβ6 expression effects on gastric carcinoma invasiveness and progression via cancer-associated fibroblastsMedical Oncology, 2013
- Targeted drug delivery for cancer therapy: the other side of antibodiesJournal of Hematology & Oncology, 2012
- Pharmacokinetically Stabilized Cystine Knot Peptides That Bind Alpha-v-Beta-6 Integrin with Single-Digit Nanomolar Affinities for Detection of Pancreatic CancerClinical Cancer Research, 2012
- Integrins in Cell MigrationCold Spring Harbor Perspectives in Biology, 2011
- Targeted In vivo Imaging of Integrin αvβ6 with an Improved Radiotracer and Its Relevance in a Pancreatic Tumor ModelCancer Research, 2009
- Engineering a Single-Chain Fv Antibody to αvβ6 Integrin Using the Specificity-Determining Loop of a Foot-and-Mouth Disease VirusJournal of Molecular Biology, 2008
- Foot-and-Mouth Disease Virus Forms a Highly Stable, EDTA-Resistant Complex with Its Principal Receptor, Integrin αvβ6: Implications for InfectiousnessJournal of Virology, 2008
- Specificity of the VP1 GH Loop of Foot-and-Mouth Disease Virus for αv IntegrinsJournal of Virology, 2006
- Reciprocal interactions between adhesion receptor signaling and MMP regulationCancer and Metastasis Reviews, 2006
- αvβ6 Integrin-A Marker for the Malignant Potential of Epithelial Ovarian CancerJournal of Histochemistry & Cytochemistry, 2002